Boenning & Scattergood’s Sanofi SNY Stock Holding History

Boenning & Scattergood’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$993K	Sell	19,346 -2	-0%	-$88	0.16%	156
2022 Q3	$736K	Hold	19,348	–	–	0.15%	159
2022 Q2	$968K	Buy	19,348 +2	+0%	+$106	0.18%	134
2022 Q1	$993K	Buy	19,346 +436	+2%	+$22.5K	0.16%	156
2021 Q4	$947K	Buy	18,910 +1	+0%	+$49	0.15%	156
2021 Q3	$911K	Sell	18,909 -1	-0%	-$51	0.16%	151
2021 Q2	$996K	Buy	18,910 +2	+0%	+$104	0.17%	146
2021 Q1	$935K	Hold	18,908	–	–	0.18%	140
2020 Q4	$919K	Buy	18,908 +280	+2%	+$13.8K	0.19%	131
2020 Q3	$935K	Hold	18,628	–	–	0.22%	115
2020 Q2	$951K	Sell	18,628 -5,183	-22%	-$252K	0.25%	99
2020 Q1	$1.04M	Sell	23,811 -1,200	-5%	-$57.4K	0.36%	76
2019 Q4	$1.26M	Hold	25,011	–	–	0.32%	78
2019 Q3	$1.16M	Hold	25,011	–	–	0.33%	82
2019 Q2	$1.08M	Buy	25,011 +16	+0.1%	+$680	0.32%	93
2019 Q1	$1.11M	Hold	24,995	–	–	0.33%	85
2018 Q4	$1.08M	Buy	24,995 +733	+3%	+$32.3K	0.38%	80
2018 Q3	$1.08M	Sell	24,262 -175	-0.7%	-$7.48K	0.34%	81
2018 Q2	$978K	Buy	+24,437	New	+$962K	0.32%	94

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boenning & Scattergood's SNY Position: Q4 2022 in Review

Boenning & Scattergood reduced its Sanofi (SNY) stake by 0.01% in Q4 2022, selling an estimated $88 and leaving 19,346 shares worth $993K. The position accounts for 0.16% of the portfolio, ranked #156.

Boenning & Scattergood first reported a position in SNY in Q2 2018 and has held it in 19 quarters since. The position peaked at $1.26M in Q4 2019. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Boenning & Scattergood held 19,346 shares of Sanofi worth $993K as of Q4 2022.
Boenning & Scattergood sold 2 Sanofi shares in Q4 2022, an estimated $88.
Sanofi made up 0.16% of Boenning & Scattergood's portfolio in Q4 2022, its #156 holding.
Boenning & Scattergood first reported a position in Sanofi in Q2 2018 and has held it in 19 quarters since.
Boenning & Scattergood's Sanofi position peaked at $1.26M in Q4 2019.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.